ABBV FY 2015 Earnings Report — AbbVie Inc. Revenue & Financial Results | Market Cap Arena

AbbVie Inc.ABBV

FY 2015 Earnings

Reported February 19, 2016

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2015	Prior Q	FY 2014	QoQ Change	YoY Change
Revenue	$22.9B	—	$20.0B	—	14.5%
Op. Income	$7.5B	—	$3.4B	—	121.0%
Gross Margin	80.3%	—	77.8%	—	2.5pp
Net Margin	22.5%	—	8.9%	—	13.6pp
EPS (Diluted)	$3.13	—	$1.10	—	184.5%
Free Cash Flow	$7.0B	—	$2.9B	—	138.4%

Revenue Flow

Item	Amount
REVENUE	$22.9B
Cost of Revenue	$4.5B
GROSS PROFIT	$18.4B
R&D Expenses	$4.4B
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$6.4B
Other Expenses	$0
Operating Expenses	$10.8B
Cost & Expenses	$15.3B
OPERATING INCOME	$7.5B
Interest Income	$33M
Interest Expense	$719M
Other Income/Expenses	-$892M
INCOME BEFORE TAX	$6.6B
Income Tax Expense	$1.5B
Net Income from Continuing Ops	$5.1B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$5.1B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$5.1B
D&A	$836M
EBIT	$7.4B
EBITDA	$8.2B
EPS	$3
EPS Diluted	$3

Income Statement

Item	Amount
REVENUE	$22.9B
Cost of Revenue	$4.5B
GROSS PROFIT	$18.4B
R&D Expenses	$4.4B
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$6.4B
Other Expenses	$0
Operating Expenses	$10.8B
Cost & Expenses	$15.3B
OPERATING INCOME	$7.5B
Interest Income	$33M
Interest Expense	$719M
Other Income/Expenses	-$892M
INCOME BEFORE TAX	$6.6B
Income Tax Expense	$1.5B
Net Income from Continuing Ops	$5.1B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$5.1B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$5.1B
D&A	$836M
EBIT	$7.4B
EBITDA	$8.2B
EPS	$3
EPS Diluted	$3

Cash Flow Statement

Item	Amount
Net Income	$5.1B
Depreciation & Amortization	$836M
Stock-Based Compensation	$282M
Deferred Income Tax	$0
Other Non-Cash Items	$769M
Change in Working Capital	$504M
OPERATING CASH FLOW	$7.5B
Capital Expenditure	-$532M
Acquisitions (Net)	-$12.5B
Purchases of Investments	-$851M
Sales/Maturities of Investments	$880M
Other Investing Activities	$19M
NET CASH FROM INVESTING	-$12.9B
Net Debt Issuance	$16.6B
Common Stock Repurchased	-$7.6B
Common Dividends Paid	-$3.3B
Other Financing Activities	$9M
NET CASH FROM FINANCING	$5.8B
FREE CASH FLOW	$7.0B
Net Change in Cash	$51M

Balance Sheet

Item	Amount
Cash & Equivalents	$8.4B
Short-Term Investments	$8M
Net Receivables	$4.7B
Inventory	$1.7B
Other Current Assets	$0
TOTAL CURRENT ASSETS	$16.3B
PP&E (Net)	$2.6B
Goodwill	$13.2B
Intangible Assets	$19.7B
Long-Term Investments	$145M
Tax Assets	$0
Other Non-Current Assets	$1.1B
TOTAL NON-CURRENT ASSETS	$36.7B
TOTAL ASSETS	$53.0B
Account Payables	$1.6B
Short-Term Debt	$2.4B
Deferred Revenue	$0
Other Current Liabilities	$924M
TOTAL CURRENT LIABILITIES	$10.9B
Long-Term Debt	$29.2B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$6.2B
Other Non-Current Liabilities	$2.8B
TOTAL NON-CURRENT LIABILITIES	$38.2B
TOTAL LIABILITIES	$49.1B
Common Stock	$17M
Additional Paid-In Capital	$13.1B
Retained Earnings	$2.2B
Treasury Stock	-$8.8B
Accum. Other Comp. Income	-$2.6B
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$3.9B
Minority Interest	$0
TOTAL EQUITY	$3.9B
TOTAL LIABILITIES & EQUITY	$53.0B
Total Debt	$31.7B
Net Debt	$23.3B